{"nctId":"NCT00103857","briefTitle":"MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)","startDateStruct":{"date":"2005-03-17","type":"ACTUAL"},"conditions":["Type 2 Diabetes Mellitus"],"count":1208,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: MK0431 100 mg q.d. (q.d. = once daily)"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Comparator: Metformin 500 mg b.i.d."]},{"label":"3","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Comparator: Metformin 1000 mg b.i.d."]},{"label":"4","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: MK0431 50 mg b.i.d. (b.i.d. = twice daily)","Drug: Comparator: Metformin 500 mg b.i.d."]},{"label":"5","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: MK0431 50 mg b.i.d. (b.i.d. = twice daily)","Drug: Comparator: Metformin 1000 mg b.i.d."]},{"label":"6","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Comparator: Placebo (Phase A)/Metformin (Phase B)"]},{"label":"7","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: Open-Label MK0431/Metformin 50/1000 mg b.i.d."]}],"interventions":[{"name":"Comparator: MK0431 50 mg b.i.d. (b.i.d. = twice daily)","otherNames":["MK0431"]},{"name":"Comparator: MK0431 100 mg q.d. (q.d. = once daily)","otherNames":[]},{"name":"Comparator: Placebo (Phase A)/Metformin (Phase B)","otherNames":[]},{"name":"Comparator: Metformin 500 mg b.i.d.","otherNames":[]},{"name":"Comparator: Open-Label MK0431/Metformin 50/1000 mg b.i.d.","otherNames":[]},{"name":"Comparator: Metformin 1000 mg b.i.d.","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n54-Week Base Study:\n\n* Patients between the ages of 18 and 78 with Type 2 Diabetes Mellitus (a specific type of diabetes)\n\n  50-Week Extension Study:\n* Patients who complete the 54-week base study are eligible to enter the 50-week extension study\n\nExclusion Criteria:\n\n* Patients who do not have Type 2 Diabetes Mellitus (a specific type of diabetes)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"78 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in HbA1c (Hemoglobin A1C) at Week 24","description":"HbA1c is measured as a percent. This change from baseline reflects the Week 24 HbA1c percent minus the Week 0 HbA1c percent.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.66","spread":null},{"groupId":"OG001","value":"-0.82","spread":null},{"groupId":"OG002","value":"-1.13","spread":null},{"groupId":"OG003","value":"-1.40","spread":null},{"groupId":"OG004","value":"-1.90","spread":null},{"groupId":"OG005","value":"0.17","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in FPG (Fasting Plasma Glucose) at Week 24","description":"Change from baseline at Week 24 is defined as Week 24 minus Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.5","spread":null},{"groupId":"OG001","value":"-27.3","spread":null},{"groupId":"OG002","value":"-29.3","spread":null},{"groupId":"OG003","value":"-47.1","spread":null},{"groupId":"OG004","value":"-63.9","spread":null},{"groupId":"OG005","value":"5.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in 2-Hour PMG (Post-Meal Glucose) at Week 24","description":"Change from baseline at Week 24 is defined as Week 24 minus Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-51.9","spread":null},{"groupId":"OG001","value":"-53.4","spread":null},{"groupId":"OG002","value":"-78.0","spread":null},{"groupId":"OG003","value":"-92.5","spread":null},{"groupId":"OG004","value":"-116.6","spread":null},{"groupId":"OG005","value":"0.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in HbA1c (Hemoglobin A1C) at Week 54","description":"HbA1c is measured as a percent. This change from baseline reflects the Week 54 HbA1c percent minus the Week 0 HbA1c percent.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.82","spread":null},{"groupId":"OG001","value":"-1.01","spread":null},{"groupId":"OG002","value":"-1.34","spread":null},{"groupId":"OG003","value":"-1.41","spread":null},{"groupId":"OG004","value":"-1.80","spread":null},{"groupId":"OG005","value":"-1.10","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in FPG (Fasting Plasma Glucose) at Week 54","description":"Change from baseline at Week 54 is defined as Week 54 minus Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.0","spread":null},{"groupId":"OG001","value":"-29.0","spread":null},{"groupId":"OG002","value":"-39.6","spread":null},{"groupId":"OG003","value":"-42.5","spread":null},{"groupId":"OG004","value":"-55.6","spread":null},{"groupId":"OG005","value":"-43.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in 2-Hour PMG (Post-Meal Glucose) at Week 54","description":"Change from baseline at Week 54 is defined as Week 54 minus Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-45.9","spread":null},{"groupId":"OG001","value":"-58.6","spread":null},{"groupId":"OG002","value":"-76.3","spread":null},{"groupId":"OG003","value":"-89.6","spread":null},{"groupId":"OG004","value":"-107.9","spread":null},{"groupId":"OG005","value":"-80.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in HbA1c (Hemoglobin A1C) at Week 104","description":"HbA1c is measured as a percent. This change from baseline reflects the Week 104 HbA1c percent minus the Week 0 HbA1c percent.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.15","spread":null},{"groupId":"OG001","value":"-1.06","spread":null},{"groupId":"OG002","value":"-1.34","spread":null},{"groupId":"OG003","value":"-1.39","spread":null},{"groupId":"OG004","value":"-1.66","spread":null},{"groupId":"OG005","value":"-1.39","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in FPG (Fasting Plasma Glucose) at Week 104","description":"Change from baseline at Week 104 is defined as Week 104 minus Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-26.8","spread":null},{"groupId":"OG001","value":"-41.4","spread":null},{"groupId":"OG002","value":"-43.2","spread":null},{"groupId":"OG003","value":"-47.5","spread":null},{"groupId":"OG004","value":"-57.3","spread":null},{"groupId":"OG005","value":"-45.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in 2-Hour PMG (Post-Meal Glucose) at Week 104","description":"Change from baseline at Week 104 is defined as Week 104 minus Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-74.1","spread":null},{"groupId":"OG001","value":"-72.7","spread":null},{"groupId":"OG002","value":"-86.7","spread":null},{"groupId":"OG003","value":"-96.2","spread":null},{"groupId":"OG004","value":"-110.0","spread":null},{"groupId":"OG005","value":"-93.3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":15},"commonTop":["Any Infections And Infestations","Any Gastrointestinal Disorders","Any Musculoskeletal And Connective Tissue Disorders","Diarrhoea","Upper Respiratory Tract Infection"]}}}